Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IKT
IKT logo

IKT Technical

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Technical Sentiment

Overall Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
4

Technical Analysis Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
4

Moving Average Consensus

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
0
Inhibikase Therapeutics Inc (IKT) Moving Averages Convergence Divergence (MACD) indicator is -0.0558, suggesting IKT is Strong Sell.
Inhibikase Therapeutics Inc (IKT) 20-Day simple moving average is 1.837, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it Sell.
Inhibikase Therapeutics Inc (IKT) 60-Day simple moving average is 1.777, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it Sell.

Technical Analysis for IKT

Technical Sentiment Analysis for Inhibikase Therapeutics Inc (IKT) As of 2026-03-30, Inhibikase Therapeutics Inc (IKT) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 16 technical signals, shows that 4 indicators are flashing buy, while 12 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for IKT stands at 35.1, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0558, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 12.245 and the Commodity Channel Index (CCI) at -137.216 further confirm a -0.4 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, IKT is trading above its 60-day moving average of $1.777 and above its 200-day long-term moving average of $1.702. Key price levels to watch include the immediate resistance at $2.002 and strong support at $1.512. A break above $2.002 could signal a bull continuation, while falling below $1.512 may test the next Fibonacci floor at $1.296.

Inhibikase Therapeutics Inc (IKT) Support & Resistance Level

NameS3S2S1Pivot PointsR1R2R3
Classic1.0221.2961.5121.7862.0022.2762.492
Fibonacci1.2961.4831.5991.7861.9732.0892.276

Inhibikase Therapeutics Inc (IKT) Technical Indicators

2026-03-30

NameValue
RSI_1435.1
STOCHk_14_3_312.245
STOCHd_14_3_312.698
CCI_20-137.216
AO_5_34-0.189
MOM_10-0.4
MACD_12_26_9 -0.0558
Inhibikase Therapeutics Inc (IKT) Relative Strength Index (RSI) is 35.1, creating a Neutral signal.
Inhibikase Therapeutics Inc (IKT) Stochastic Oscillator is 12.245, creating a Buy signal.
Inhibikase Therapeutics Inc (IKT) Stochastic RSI is 12.698, creating a Buy signal.
Inhibikase Therapeutics Inc (IKT) Commodity Channel Index (CCI) is -137.216, creating a Buy signal.
Inhibikase Therapeutics Inc (IKT) Awesome Oscillator is -0.189, creating a Sell signal.
Inhibikase Therapeutics Inc (IKT) Momentum is -0.4, creating a Sell signal.
Inhibikase Therapeutics Inc (IKT) MACD is -0.0558, creating a Sell signal.

Inhibikase Therapeutics Inc (IKT) Moving Average

2026-03-30

PeriodSimpleSignal
MA_51.624Sell
MA_101.728Sell
MA_201.837Sell
MA_601.777Sell
MA_2001.702Sell
MA_2501.763Sell
Inhibikase Therapeutics Inc (IKT) 5-Day simple moving average is 1.624, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.
Inhibikase Therapeutics Inc (IKT) 10-Day simple moving average is 1.728, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.
Inhibikase Therapeutics Inc (IKT) 20-Day simple moving average is 1.837, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.
Inhibikase Therapeutics Inc (IKT) 60-Day simple moving average is 1.777, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.
Inhibikase Therapeutics Inc (IKT) 200-Day simple moving average is 1.702, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.
Inhibikase Therapeutics Inc (IKT) 250-Day simple moving average is 1.763, while Inhibikase Therapeutics Inc (IKT) share price is $1.58, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for IKT?

The overall technical consensus for Inhibikase Therapeutics Inc (IKT) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 6 sell signals.

What are the key support and resistance levels for Inhibikase Therapeutics Inc (IKT) today?

Based on pivot point calculations, Inhibikase Therapeutics Inc (IKT) has an immediate support level at 1.512 and a major resistance level at 2.002. Traders also monitor the pivot point at 1.786 to determine the intraday trend direction.

Is Inhibikase Therapeutics Inc (IKT) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Inhibikase Therapeutics Inc (IKT) is currently 35.1. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Inhibikase Therapeutics Inc (IKT)?

Inhibikase Therapeutics Inc (IKT) Moving Averages Convergence Divergence (MACD) indicator is -0.0558, suggesting IKT is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Inhibikase Therapeutics Inc.

How is Inhibikase Therapeutics Inc (IKT) performing relative to its 200-day moving average?

Inhibikase Therapeutics Inc (IKT) is currently trading at $1.58, which is below its 200-day simple moving average of 1.702. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.